A judge has decided that the owners of a southern Indiana concert hall destroyed in an arson nearly two years ago aren't owed any insurance money because they didn't properly maintain the sprinkler system.
Janssen Pharmaceutica said Thursday it has completed the sale of its animal health business to Eli Lilly and Co. Inc.
Lilly executives are emphatic that they have no plans to reduce the company's 49-cents-a-share quarterly cash dividend, which gives the stock a rich annual yield of 5.2 percent.
The fact is that hospitals are paid three to four times for physician ancillary services.
Partnership combines wellness, hospital services.
Used parts are in demand as health care reform changes industry dynamic.
Companies that drop insurance coverage could, without spending any more money than they are now, give workers an 11-percent raise or else help them save as much as $2,000 per year buying health coverage in one of the exchanges, IBJ calculations show.
CEO Jim Prieur got more than he bargained for when he took over CNO Financial Group (then-Conseco) five years ago, but he said he’s ready to step down now that the insurer is in good shape.
Jim Prieur will retire as CEO of CNO Financial Group Inc. on Sept. 30 and will replaced by the company’s chief financial officer, Ed Bonach, the company announced Wednesday.
Bolingbrook, Ill.-based ATI Physical Therapy has acquired Advanced Physical Therapy, which has 175 employees and ranks among the city’s largest operators of physical therapy clinics.
Health insurer WellPoint Inc. will pay $100,000 and take other steps after admitting it waited months to notify 32,000 Indiana customers that their Social Security numbers, health records and other personal information might have been exposed online.
A company that reconditions hospital beds plans to expand its operations in southeastern Indiana and potentially add 55 jobs in the next couple of years.
To understand the depths of the pharmaceutical industry’s recent struggles, consider this: The industry has been spending $57 billion more per year on research and development than the value of the products it has been launching. That’s a problem.
Eli Lilly and Co., the Indianapolis-based drugmaker whose best-selling schizophrenia medicine Zyprexa survived a patent challenge in Britain two years ago, has asked a United Kingdom judge to reject a parallel lawsuit by a generic drug company.
Eli Lilly and Co.’s foray into combination drugs is well-timed because the company could take advantage of some the world’s most successful biotech medicines, which are about to see their patents expire.
Marvin Pember, 58, is taking a new job near Philadelphia as the president of the acute care division of Universal Health Services Inc., a publicly traded company with 22 acute hospitals and numerous behavioral health centers spread from coast to coast.
A Hamilton County jury sided with Joseph Radcliff in his lengthy legal battle with the insurer following a 2006 hailstorm that caused severe damage in central Indiana. State Farm accused Radcliff of fraud.
Lilly has 33 drugs in the second and third stages of clinical trials, including medicines for cancer, diabetes and Alzheimer’s disease, up from seven in 2005, the Indianapolis-based company said Thursday.
Indianapolis-based Eli Lilly and Co. raised its spending 8 percent from the $2.3 million that it spent in the first quarter of last year. The drugmaker also spent 70 percent more than the $1.5 million recorded in the final quarter of 2010, according to lobbying reports filed with the House of Representatives.
WellPoint Inc., the nation's largest health insurer based on membership, spent about $1.5 million lobbying the federal government in the first quarter, as the health care overhaul debuted a new restriction that concerned managed care companies.
